Dr. Hyland received his doctorate in biochemistry from Brunel University, United Kingdom in 1980. His fellowships included Gustave Roussy Institute, Department of Biochemistry and Enzymology in Paris and the Department of Child Health, Institute of Child Health at the University of London.
In 1989 Dr. Hyland moved from the Institute of Child Health in London, where he had advanced to a lecturer in Biochemistry, to the Baylor Research Institute in Dallas, Texas where he held the positions of Senior Research Scientist at the Baylor Research Institute, Adjunct professor of Neurology at the University of Texas, Southwestern Medical Center and Professor of Biomedical Sciences at Baylor University.
In 2004, he moved to Atlanta to join Horizon Molecular Medicine, which became Medical Neurogenetics LLC in 2008.
In a career spanning 35 years, he has led numerous grant funded research teams in the UK and the US in the study of inherited disease and the neuroprotective molecular medicines used to treat them. He is a leading expert in the area of inherited disorders affecting serotonin, catecholamine, folate, and pyridoxal phosphate metabolism.
Dr. Hyland has been honored for his work in the area of Neurometabolic Disease, including the Noel Raine Award from the Society for the Study of Inborn Errors of Metabolism (1989 and 1998).